Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optivate in Severe Haemophilia A
NCT02246868Phase 3Completed
- Sponsor
- Bio Products Laboratory
- Start
- Sep 2001
- Primary completion
- Aug 2004
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 2
01
Overview
A Phase 3 trial of factor viii + von Willebrand factor in hemophilia A, sponsored by Bio Products Laboratory. Started Sep 2001; status: completed.
02
Drugs
factor viii + von Willebrand factor
03
Conditions
hemophilia A
Beyond the preview
Go deeper on NCT02246868.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02246868.